🇺🇸 FDA
Company

Voyager

Voyager Therapeutics

VYGR biotech USA

Quick answer

Voyager is a biotech company (VYGR) headquartered in LEXINGTON, MA, USA with 4 tracked pipeline programs.

Pipeline (4)

project

VP4896

Alzheimer's Disease

Phase 3 · small_molecule · completed

1 trials project

Leuprolide acetate

Alzheimer Disease

Phase 2 · small_molecule · completed

2 trials project

VY7523

Alzheimer's Disease (AD)

Phase 2 · small_molecule · active

1 trials project

Intraparenchymal rAAV1 - (mi)RNA HTT

Huntington Disease

Phase 1 · gene_therapy · terminated

1 trials

Patents (8)

patent

US 12419969

AAV capsid variants and uses thereof

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12319929

Compositions and methods for the treatment of Parkinson's disease

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12305189

Compositions and methods for delivery of AAV

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12296025

AAV capsid variants and uses thereof

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12291565

Tau binding compounds

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12281321

Frataxin expression constructs having engineered promoters and methods of use th

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12252703

Closed-ended linear duplex DNA for non-viral gene transfer

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12146150

Rescue of central and peripheral neurological phenotype of friedreich's ataxia b

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)